Leonard Shultz to Imatinib Mesylate
This is a "connection" page, showing publications Leonard Shultz has written about Imatinib Mesylate.
Connection Strength
0.022
-
Zhang B, Strauss AC, Chu S, Li M, Ho Y, Shiang KD, Snyder DS, Huettner CS, Shultz L, Holyoake T, Bhatia R. Effective targeting of quiescent chronic myelogenous leukemia stem cells by histone deacetylase inhibitors in combination with imatinib mesylate. Cancer Cell. 2010 May 18; 17(5):427-42.
Score: 0.022